摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-甲基酪胺 | 370-98-9

中文名称
N-甲基酪胺
中文别名
4-[2-(甲基氨基)乙基]苯酚;N-甲基-4-羟基苯乙胺
英文名称
N-methyltyramine
英文别名
N-methyl-p-Tyramine;N‐acetylnorsynephrine;NMT;4-(2-methylamino-ethyl)-phenol;4-(2-Methylamino-aethyl)-phenol;Methyl-[β-(4-oxy-phenyl)-aethyl]-amin;4-[2-(methylamino)ethyl]phenol
N-甲基酪胺化学式
CAS
370-98-9
化学式
C9H13NO
mdl
——
分子量
151.208
InChiKey
AXVZFRBSCNEKPQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    130~131℃
  • 沸点:
    270.9±15.0 °C(Predicted)
  • 密度:
    1.035±0.06 g/cm3(Predicted)
  • 溶解度:
    可溶于DMSO(少许)、甲醇(少许)
  • 物理描述:
    Solid
  • 保留指数:
    1449.9

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    32.3
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2922299090
  • 储存条件:
    | 2-8°C |

SDS

SDS:314d7a37aa052abdb889d61898806477
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: N-Methyl-p-tyramine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: N-Methyl-p-tyramine
CAS number: 370-98-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H13NO
Molecular weight: 151.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

简介

N-甲基酪胺的分子量为151,是一种白色棱柱结晶(在乙醇中)或片状结晶(在苯中),熔点为130~131°C,沸点为183~185°C,微溶于。它是重要药物合成中间体。

用途

N-甲基酪胺盐酸盐有助于促进新陈代谢,具有增加冠脉血流量和肾脏血流量、降低心肌耗氧量以及明显的利尿作用。它还表现出强力的升压效果,并能诱发心肌节律,其强度与肾上腺素相当,比多巴胺和对羟弗林强。因此,它是优良的抗休克药物。

此外,N-甲基酪胺盐酸盐也具有抑制细菌生长的作用,可用作防腐剂和抗菌剂,在食品、化妆品等领域中广泛应用。近年来,由于其用途日益广泛,需求量也随之增加,使其成为重要的药物合成中间体之一。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    甲基酪氨酸二甲基硫酸盐及其衍生物
    摘要:
    酪氨酸二酪胺在酪氨酸-酪氨酸-丁二酮-对甲氧基苯甲酸酯中的应用。Tyrosinbetainbzw。乐观主义者Ratanhin。N-甲基酪氨酸,3-硝基-N-甲基酪氨酸,3-硝基-N-甲基酪氨酸,3-硝基-N-甲基-N-甲基-N-乙酰基酪氨酸,3-氨基-N-甲基-N-乙酰酪氨酸和3-氨基-N-甲基酪氨酸酯。
    DOI:
    10.1002/hlca.19490320309
  • 作为产物:
    参考文献:
    名称:
    The Biogenesis of Alkaloids. I. The Isolation of N-Methyltyramine from Barley1
    摘要:
    DOI:
    10.1021/ja01162a050
  • 作为试剂:
    描述:
    正丁醛N-甲基酪胺 作用下, 反应 24.0h, 以35%的产率得到2-乙基-2-己烯醛
    参考文献:
    名称:
    酪胺衍生物在大肠杆菌存在下催化丁醛的羟醛二聚
    摘要:
    细菌胺有机催化:发现源自 L-酪氨酸的生物胺在大肠杆菌存在下催化丁醛的生物相容性自羟醛二聚化。大肠杆菌和谷氨酸棒杆菌的细胞裂解物也被发现能在体外催化这一反应。在生物相容性条件下,产物烯醛通过内源性还原酶还原为2-乙基己醛。
    DOI:
    10.1002/cbic.202200238
点击查看最新优质反应信息

文献信息

  • [EN] ASPARAGINE DERIVATIVES AND METHODS OF USING SAME<br/>[FR] DÉRIVÉS D'ASPARAGINE ET LEURS PROCÉDÉS D'UTILISATION
    申请人:SENDA BIOSCIENCES INC
    公开号:WO2021252640A1
    公开(公告)日:2021-12-16
    The present disclosure relates to compounds of formulas (A) and (I), pharmaceutically acceptable salts thereof, and solvates of any of the foregoing, pharmaceutical compositions comprising the same, methods of preparing the same, intermediate compounds useful for preparing the same, and methods for treating or prophylaxis of diseases, in particular cancer, such as colorectal cancer, using the same.
    本公开涉及式(A)和(I)的化合物,其药学上可接受的盐,以及任何上述化合物的溶剂化合物,包括相同的药物组合物,制备相同的方法,用于制备相同的中间化合物,以及使用相同的方法治疗或预防疾病,特别是癌症,如结直肠癌。
  • [EN] COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR<br/>[FR] COMPOSÉS ET PROCÉDÉS DE MODULATION DU RÉCEPTEUR A2B DE L'ADÉNOSINE ET DU RÉCEPTEUR A2A DE L'ADÉNOSINE
    申请人:CORVUS PHARMACEUTICALS INC
    公开号:WO2019046784A1
    公开(公告)日:2019-03-07
    Disclosed herein, inter alia, are compositions and methods for modulating Adenosine Receptors. In an aspect is provided a method of inhibiting Adenosine A2B Receptor activity and Adenosine A2A Receptor activity, the method including contacting the Adenosine A2B Receptor and Adenosine A2A Receptor with a compound as described herein, including embodiments.
    在此披露的内容包括调节腺苷受体的组合物和方法。在一个方面,提供了一种抑制腺苷A2B受体活性和腺苷A2A受体活性的方法,该方法包括将腺苷A2B受体和腺苷A2A受体与本文描述的化合物接触,包括各种实施方式。
  • Dolastatin 10 derivatives
    申请人:——
    公开号:US20030055002A1
    公开(公告)日:2003-03-20
    Novel anti-tumor compounds of formula, 1 are disclosed. Also disclosed are pharmaceutical compositions comprising compounds of formula (I), the use of compounds of formula (I) for the treatment of cancer, and processes for the preparation of compounds (I).
    揭示了一种新型的抗肿瘤化合物,其化学式为1。还揭示了包含化合物(I)的药物组合物,化合物(I)用于治疗癌症的用途,以及化合物(I)的制备过程。
  • [EN] COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS<br/>[FR] COMPOSES ET COMPOSITIONS UTILISES COMME INHIBITEURS DE LA CATHEPSINE S
    申请人:NOVARTIS AG
    公开号:WO2006018284A1
    公开(公告)日:2006-02-23
    The present invention relates to the use of a 2-cyanopyrimidine compound of the formula (I), wherein R1, R2, R3 and X are as defined in the specification and in the claims, in free form or in salt form, and , where possible, in tautomeric form, as an inhibitor of the activity of cathepsin S.
    本发明涉及使用式(I)的2-氰基嘧啶化合物,其中R1、R2、R3和X如规范和权利要求中定义的那样,以自由形式或盐形式,并在可能的情况下以互变异构形式,作为猫hepsin S活性的抑制剂
  • Selective Monomethylation of Amines with Methanol as the C <sub>1</sub> Source
    作者:Geunho Choi、Soon Hyeok Hong
    DOI:10.1002/anie.201801524
    日期:2018.5.22
    methanol as the methylating agent, which is a sustainable chemical feedstock. Kinetic control of the aliphatic amine monomethylation was achieved by using a readily available ruthenium catalyst at an adequate temperature under hydrogen pressure. Various substrates including bio‐related molecules and pharmaceuticals were selectively monomethylated, demonstrating the general utility of the developed method
    N-单甲基官能团是多种合成和天然化合物中的常见基序。然而,由于由过度甲基化引起的选择性问题,容易获得此类化合物仍然是有机合成中的基本挑战。为了解决这个问题,我们开发了一种方法,可以使用甲醇作为甲基化剂,对各种结构和功能多样的胺(包括通常存在问题的伯脂肪族伯胺)进行选择性催化单甲基化,这是一种可持续的化学原料。通过使用容易获得的催化剂在适当的温度和氢气压力下实现脂肪族胺单甲基化的动力学控制。各种底物(包括与生物有关的分子和药物)被选择性地单甲基化,
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫